136 related articles for article (PubMed ID: 17551391)
1. Use of adalimumab in poststreptococcal reactive arthritis.
Sánchez-Cano D; Callejas-Rubio JL; Ortego-Centeno N
J Clin Rheumatol; 2007 Jun; 13(3):176. PubMed ID: 17551391
[No Abstract] [Full Text] [Related]
2. [Treatment of reactive arthritis with infliximab].
Abdelmoula LC; Yahia CB; Testouri N; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
Tunis Med; 2008 Dec; 86(12):1095-7. PubMed ID: 19213526
[No Abstract] [Full Text] [Related]
3. Adalimumab for rheumatoid arthritis?
Ebell M; Kripke C
Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
[No Abstract] [Full Text] [Related]
4. Adalimumab in juvenile rheumatoid arthritis.
de Vries MK; van der Horst-Bruinsma IE; Wolbink GJ
N Engl J Med; 2008 Dec; 359(23):2496; author reply 2496-7. PubMed ID: 19065700
[No Abstract] [Full Text] [Related]
5. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
6. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
Nagashima T; Minota S
J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
[No Abstract] [Full Text] [Related]
7. Adalimumab in juvenile rheumatoid arthritis.
Taddio A; Marchetti F
N Engl J Med; 2008 Dec; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
[No Abstract] [Full Text] [Related]
8. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease.
Cepeda EJ; Williams FM; Ishimori ML; Weisman MH; Reveille JD
Ann Rheum Dis; 2008 May; 67(5):710-2. PubMed ID: 18079191
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab in juvenile rheumatoid arthritis.
Sfriso P; Ravaioli F
N Engl J Med; 2008 Dec; 359(23):2495; author reply 2496-7. PubMed ID: 19052133
[No Abstract] [Full Text] [Related]
10. Adalimumab therapy in rheumatoid arthritis.
Keystone E; Haraoui B
Rheum Dis Clin North Am; 2004 May; 30(2):349-64, vii. PubMed ID: 15172045
[TBL] [Abstract][Full Text] [Related]
11. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
[No Abstract] [Full Text] [Related]
12. Tumor necrosis factor inhibitors for rheumatoid arthritis.
Scott DL; Kingsley GH
N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
[No Abstract] [Full Text] [Related]
13. Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis.
Seymour MW; Home DM; Williams RO; Allard SA
Rheumatology (Oxford); 2007 Nov; 46(11):1738-9. PubMed ID: 17933796
[No Abstract] [Full Text] [Related]
14. Mycobacterium chelonae infection associated with adalimumab therapy.
Díaz F; Urkijo JC; Mendoza F; de la Viuda JM; Blanco M; Unzurrunzaga A; Ayarza R
Scand J Rheumatol; 2008; 37(2):159-60. PubMed ID: 18415777
[No Abstract] [Full Text] [Related]
15. Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha.
van Lieshout AW; Creemers MC; Radstake TR; Elving LD; van Riel PL
J Rheumatol; 2008 May; 35(5):938-9. PubMed ID: 18464319
[No Abstract] [Full Text] [Related]
16. Systemic listeriosis with adalimumab therapy.
Murphy G; Schmidt-Martin D; Hynes BG; Harney S
J Clin Rheumatol; 2009 Oct; 15(7):369-70. PubMed ID: 20009978
[No Abstract] [Full Text] [Related]
17. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
[No Abstract] [Full Text] [Related]
18. Adalimumab-associated multiple sclerosis.
Bensouda-Grimaldi L; Mulleman D; Valat JP; Autret-Leca E
J Rheumatol; 2007 Jan; 34(1):239-40; discussion 240. PubMed ID: 17216704
[No Abstract] [Full Text] [Related]
19. Rheumatoid arthritis.
Burchini G; Orsi C
N Engl J Med; 2004 Sep; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
[No Abstract] [Full Text] [Related]
20. Development of alopecia areata universalis in a patient receiving adalimumab.
Garcia Bartels N; Lee HH; Worm M; Burmester GR; Sterry W; Blume-Peytavi U
Arch Dermatol; 2006 Dec; 142(12):1654-5. PubMed ID: 17179003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
